Publications by authors named "Isla Johnson"

Claim this Profile
M
Molecular predictors of response and survival in patients with relapsed/refractory acute myeloid leukemia following venetoclax plus hypomethylating agent therapy.
Isla M Johnson, Rimal Ilyas, Kristen McCullough, Aref Al-Kali, Hassan B Alkhateeb

Haematologica· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.
Naseema Gangat, Azeem Elbeih, Nour Ghosoun, Kristen McCullough, Fnu Aperna, Isla M Johnson

Am J Hematol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents.
Isla M Johnson, Omer Karrar, Masooma Rana, Moazah Iftikhar, Sunny Chen

Br J Haematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.
Naseema Gangat, Omer Karrar, Moazah Iftikhar, Kristen McCullough, Isla M Johnson

Am J Hematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burkitt Lymphoma Presenting as Ileocolic Intussusception in an Adult.
Carla Isabel Borré, Bethany Boyle, Kelsey Lynch, Anuradha Kanaparthi, Clifford Michael Csizmar, Isla McKerrow Johnson

Open J Blood Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy.
Naseema Gangat, Rimal Ilyas, Isla M Johnson, Kristen McCullough, Aref Al-Kali

Haematologica· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Pretransplantation Prediction Models for Nonrelapse Mortality in Patients with Myelofibrosis Undergoing Allogeneic Stem Cell Transplantation.
Aldo A Acosta-Medina, Anmol Baranwal, Isla McKerrow Johnson, Mohamed A Kharfan-Dabaja, Hemant Murthy

Transplant Cell Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma.
Aldo A Acosta-Medina, Isla McKerrow Johnson, Radhika Bansal, Matthew Hathcock, Saad J Kenderian

Blood Cancer J· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia.
Naseema Gangat, Isla Johnson, Kristen McCullough, Faiqa Farrukh, Aref Al-Kali

Haematologica· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatal Powassan virus encephalitis in patients with chronic lymphocytic leukemia.
Isla M Johnson, Caleb Scheckel, Sameer A Parikh, Mark Enzler, Jennifer Fugate

Blood Cancer J· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac events in patients with acute myeloid leukemia treated with venetoclax combined with hypomethylating agents.
Isla M Johnson, Evandro D Bezerra, Faiqa Farrukh, Kristen McCullough, Aref Al-Kali

Blood Adv· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts.
Naseema Gangat, Kristen McCullough, Isla Johnson, Aref Al-Kali, Kebede H Begna

Am J Hematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteolytic lesions in myelofibrosis.
Isla Johnson, Hassan Alkhateeb

Clin Case Rep· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first-line therapy in multiple myeloma.
Joselle Cook, Isla Johnson, Alexandra Higgins, Surbhi Sidana, Rahma Warsame

Am J Hematol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis